News | Radiation Therapy | September 21, 2017

Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017

CyberKnife System with Accuray Precision TPS leads new technology highlights

Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017

September 21, 2017 — Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be shared by leading radiation oncology practitioners at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego.

Technology highlights from the show will include:

  • The CyberKnife System upgrade with the Accuray Precision Treatment Planning System (TPS): the fully integrated Accuray TPS allows clinicians to reduce treatment times, while advanced TPS features enhance workflow efficiencies;
  • The Radixact System: the next-generation TomoTherapy platform represents a major step forward in treatment speed, efficiency and ease of use, enabling customers to deliver precise radiation treatments to a high volume of patients; and
  • The CyberKnife System High-Definition ImagingRing (HDI): a cone beam computed tomography (CBCT) imaging system designed to enable both 3-D volumetric imaging and adaptive radiotherapy workflows. When paired with the system's accurate couch imaging and patient registration, along with true robotic alignment, it is projected to facilitate high precision and versatility in stereotactic radiosurgery and stereotactic body radiation therapy. The CyberKnife System HDI is a work in progress and not available for sale in any market.

ASTRO attendees can attend educational symposia and Accuray Exchange in Radiation Oncology (AERO) Academy sessions to learn about advances in clinical practice that are transforming patient experience and outcomes.

 

For more information: www.accuray.com

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Overlay Init